Cambridge Cognition Holdings Plc (AIM:COG)
London · Delayed Price · Currency is GBP · Price in GBX 35.80
+0.80 (2.29%)
May 8, 2026, 10:35 AM GMT
AIM:COG Market Cap
AIM:COG has a market cap or net worth of 16.29 million as of May 8, 2026. Its market cap has increased by 8.71% in one year.
Market Cap
16.29M
Enterprise Value
16.03M
Revenue
9.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.80
Market Cap Chart
Since April 18, 2013, AIM:COG's market cap has increased from 13.12M to 16.29M, an increase of 24.22%. That is a compound annual growth rate of 1.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 16.29M | 39.00% |
| Dec 31, 2025 | 11.72M | -24.92% |
| Dec 31, 2024 | 15.61M | -2.50% |
| Dec 29, 2023 | 16.01M | -54.81% |
| Dec 30, 2022 | 35.44M | -9.78% |
| Dec 31, 2021 | 39.28M | 88.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.50B |
| GSK plc | 74.19B |
| Haleon | 29.76B |
| Smith & Nephew | 9.51B |
| Aptamer Group | 20.73M |
| Fusion Antibodies | 16.25M |
| genedrive | 15.25M |
| IXICO | 14.99M |